Effect of salbutamol on smoking related cough.

Smokers have an increased prevalence of chronic cough and may complain of exacerbation of cough when attempting smoking cessation. We investigated the use of smokers cough as a model for testing anti-tussive agents. The effect of salbutamol was compared with placebo in healthy adult smokers. In a randomised double blind crossover study the effect of 400 microg salbutamol via MDI plus spacer versus placebo was studied. Cough was assessed before and after the first cigarette of the day (received at 20 minutes) and throughout the day. Cough frequency, citric acid cough challenge, change in cough symptoms and peak flow were recorded. Salbutamol reduced the mean cough frequency between 0 and 20 min. A mean of 4.5 compared to 6 on placebo (p<0.05). A significant reduction in cough followed cigarette consumption in those on placebo. Mean pre-cigarette 6 compared to 3.9 post-cigarette (p<0.02). The citric acid concentration causing two coughs (C2) at 60 min increased on salbutamol. Geometric mean 278.8 compared to 190.4 mM on placebo (p<0.03). Cough frequency is reduced in smokers following a cigarette. The reduction in cough frequency and evoked cough after salbutamol suggests that beta agonists have modest activity in smoking related cough and that smokers cough represents a sensitive model to test anti-tussive activity.

[1]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[2]  Christopher E Brightling,et al.  A comparison of the validity of different diagnostic tests in adults with asthma. , 2002, Chest.

[3]  D. Cockcroft,et al.  Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. , 2015, The American review of respiratory disease.

[4]  A. Morice,et al.  Cough challenge in the assessment of cough reflex. , 2001, British journal of clinical pharmacology.

[5]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.

[6]  A. Morice,et al.  Cough threshold in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[7]  G. FitzGerald,et al.  Nomenclature of isoprostanes: a proposal. , 1997, Prostaglandins.

[8]  A. Morice,et al.  Breath carbon monoxide as an indication of smoking habit. , 2000, Chest.

[9]  G. FitzGerald,et al.  Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.

[10]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[11]  D. Jarvis,et al.  Determinants of cough in young adults participating in the European Community Respiratory Health Survey. , 2001, The European respiratory journal.

[12]  N. Pride,et al.  Capsaicin cough sensitivity decreases with successful treatment of chronic cough. , 1994, American journal of respiratory and critical care medicine.

[13]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[14]  P. Cullinan,et al.  Persistent cough and sputum: prevalence and clinical characteristics in south east England. , 1992, Respiratory medicine.

[15]  J. Pounsford,et al.  Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. , 1985, Thorax.

[16]  K. Chung,et al.  Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. , 1990, Thorax.